These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9878310)

  • 1. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA; Kang Y; Greaves B; Perry RR
    J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DT-diaphorase].
    Mikami K; Shirakusa T; Tsuruo T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.
    Mikami K; Naito M; Tomida A; Yamada M; Sirakusa T; Tsuruo T
    Cancer Res; 1996 Jun; 56(12):2823-6. PubMed ID: 8665520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
    Lee JH; Naito M; Tsuruo T
    Cancer Res; 1994 May; 54(9):2398-403. PubMed ID: 8162587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C.
    Kuehl BL; Buchwald M; Rauth AM
    Oncol Res; 1993; 5(6-7):213-21. PubMed ID: 8123941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
    Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
    Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line].
    Xu B; Sun Y; Singh SV
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):343-6. PubMed ID: 8697971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
    Saeki S; Nishiyama M; Toge T
    Hiroshima J Med Sci; 1995 Sep; 44(3):55-63. PubMed ID: 8567314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.
    Wang X; Doherty GP; Leith MK; Curphey TJ; Begleiter A
    Br J Cancer; 1999 Jun; 80(8):1223-30. PubMed ID: 10376975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH; Naito M; Nakajima M; Tsuruo T
    Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
    Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
    Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the prodrug-activating enzyme DT-diaphorase via Ad5 delivery to human colon carcinoma cells in vitro.
    Misra V; Klamut HJ; Rauth AM
    Cancer Gene Ther; 2002 Feb; 9(2):209-17. PubMed ID: 11857040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
    Gan Y; Mo Y; Kalns JE; Lu J; Danenberg K; Danenberg P; Wientjes MG; Au JL
    Clin Cancer Res; 2001 May; 7(5):1313-9. PubMed ID: 11350900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
    Pan SS; Yu F; Hipsher C
    Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR; Greaves BR; Rasberry U; Barranco SC
    Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
    Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immortalisation of a human diploid fibroblast cell strain: a DT-diaphorase paradox.
    Kuehl BL; Brezden CB; Traver RD; Siegel D; Ross D; Renzing J; Rauth AM
    Br J Cancer Suppl; 1996 Jul; 27():S19-22. PubMed ID: 8763839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
    O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
    Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of a mitomycin C resistant colon cancer cell line variant.
    Perry RR; Kang Y; Greaves B
    Biochem Pharmacol; 1993 Dec; 46(11):1999-2005. PubMed ID: 7903534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.